Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Ncf1em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Ncf1em1/Cya

Common Name
Ncf1-KO
Product ID
S-KO-03333
Backgroud
C57BL/6JCya
Strain ID
KOCMP-17969-Ncf1-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Ncf1-KO Mouse (Catalog S-KO-03333) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Ncf1-KO
Strain ID
KOCMP-17969-Ncf1-B6J-VA
Gene Name
Ncf1
Product ID
S-KO-03333
Gene Alias
NOXO2, Ncf-1, NCF-47K, p47phox, p47-phox, p47<phox>
Background
C57BL/6JCya
Gene Full Name
neutrophil cytosolic factor 1
Modification
Conventional knockout
NCBI ID
17969 (Mouse)
Phenotype
MGI:97283
Chromosome
Chr 5 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000016094
NCBI Transcript ID
NM_001286037
Target Region
Exon 2~5
Size of Effective Region
~1.8 kb
Overview of Gene Research
NCF1, also known as neutrophil cytosolic factor 1 and encoding the p47phox subunit of the phagocyte NADPH oxidase, is essential in reactive oxygen species (ROS) production [3,4,6,7,8]. ROS regulated by NCF1 is involved in multiple pathways, affecting immune and inflammatory responses, and iron homeostasis [1,3]. Genetic models, such as gene knockout mice, have been crucial for studying its function in vivo.

In mouse models, Ncf1 knockout in smooth muscle cells exacerbates angiotensin II-induced aortic aneurysm and dissection by activating the STING pathway, indicating its role in preventing SMC apoptosis [2]. In the context of metabolic dysfunction-associated steatohepatitis (MASH), macrophage NCF1, but not dendritic cell NCF1, triggers Kupffer cell (KC) iron overload, ferroptosis, and monocyte-derived macrophage infiltration, aggravating MASH progression [1]. Also, the Ncf1m1j mutation, causing a deficient ROS response, alleviates antigen-induced pulmonary inflammation, enhancing Th1 response and deactivating group 2 innate lymphoid cells (ILC2) [5].

In conclusion, NCF1 plays a vital role in regulating ROS-related biological processes. Studies using Ncf1 knockout or mutated mouse models have revealed its significance in diseases like aortic aneurysm, MASH, and pulmonary inflammation. These findings provide insights into potential therapeutic targets for treating related diseases by modulating NCF1 function.

References:
1. Zhang, Jing, Wang, Yu, Fan, Meiyang, Lu, Shemin, Holmdahl, Rikard. 2024. Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH. In Cell metabolism, 36, 1745-1763.e6. doi:10.1016/j.cmet.2024.05.008. https://pubmed.ncbi.nlm.nih.gov/38851189/
2. Liu, Hao, Yang, Peiwen, Chen, Shu, Ye, Ping, Xia, Jiahong. . Ncf1 knockout in smooth muscle cells exacerbates angiotensin II-induced aortic aneurysm and dissection by activating the STING pathway. In Cardiovascular research, 120, 1081-1096. doi:10.1093/cvr/cvae081. https://pubmed.ncbi.nlm.nih.gov/38639325/
3. Holmdahl, Rikard, Sareila, Outi, Olsson, Lina M, Bäckdahl, Liselotte, Wing, Kajsa. . Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation. In Immunological reviews, 269, 228-47. doi:10.1111/imr.12378. https://pubmed.ncbi.nlm.nih.gov/26683156/
4. Zhang, Liang, Wax, Jacqueline, Huang, Renliang, Petersen, Frank, Yu, Xinhua. 2022. Meta-Analysis and Systematic Review of the Association between a Hypoactive NCF1 Variant and Various Autoimmune Diseases. In Antioxidants (Basel, Switzerland), 11, . doi:10.3390/antiox11081589. https://pubmed.ncbi.nlm.nih.gov/36009308/
5. Li, Mengyao, Zhang, Wentao, Zhang, Jing, Holmdahl, Rikard, Lu, Shemin. 2021. Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. In Frontiers in immunology, 12, 783944. doi:10.3389/fimmu.2021.783944. https://pubmed.ncbi.nlm.nih.gov/34970267/
6. Kuhns, Douglas B, Hsu, Amy P, Sun, David, Wu, Xiaolin, Gallin, John I. . NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis. In Blood advances, 3, 136-147. doi:10.1182/bloodadvances.2018023184. https://pubmed.ncbi.nlm.nih.gov/30651282/
7. Luo, Huqiao, Urbonaviciute, Vilma, Saei, Amir Ata, Zubarev, Roman A, Holmdahl, Rikard. 2023. NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions. In JCI insight, 8, . doi:10.1172/jci.insight.164875. https://pubmed.ncbi.nlm.nih.gov/36853827/
8. Meng, Yao, Ma, Jianyang, Yao, Chao, Zhou, Haibo, Shen, Nan. . The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells. In The Journal of clinical investigation, 132, . doi:10.1172/JCI153619. https://pubmed.ncbi.nlm.nih.gov/35788118/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Publications
Redox Biology
2024-10-18
Neutrophils with low production of reactive oxygen species are activated during immune priming and promote development of arthritis
Read More
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research